doi: 10.2105/ajph.82.11.1553.
A quality-of-life method for estimating the value of avoided morbidity
Affiliations
- PMID: 1443310
- PMCID: PMC1694602
- DOI: 10.2105/ajph.82.11.1553
Item in Clipboard
A quality-of-life method for estimating the value of avoided morbidity
Am J Public Health.
1992 Nov.
Abstract
We developed a quality-of-life method for valuing changes in health status. Our model determines changes in health attributes for different illnesses and then estimates the dollar value of the corresponding welfare losses. We used our quality-of-life approach to estimate willingness to pay to avoid asthma, a headache, a cough, bronchitis, and arthritis. Estimates derived using our method are similar to those obtained from more expensive and restrictive traditional methods.
Similar articles
-
Estimating the value of avoiding morbidity and mortality from foodborne illnesses.Risk Anal. 1991 Dec;11(4):619-31. doi: 10.1111/j.1539-6924.1991.tb00651.x. Risk Anal. 1991. PMID: 1780502
-
The economic value of life: linking theory to practice.Am J Public Health. 1982 Jun;72(6):555-66. doi: 10.2105/ajph.72.6.555. Am J Public Health. 1982. PMID: 6803602 Free PMC article.
-
Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US.J Environ Public Health. 2016;2016:2386596. doi: 10.1155/2016/2386596. Epub 2016 May 29. J Environ Public Health. 2016. PMID: 27313630 Free PMC article. Review.
-
Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures.J Health Econ. 1997 Dec;16(6):641-65. doi: 10.1016/s0167-6296(97)00012-x. J Health Econ. 1997. PMID: 10176777
-
Valuing reduced antibiotic use for pediatric acute otitis media.Pediatrics. 2008 Apr;121(4):669-73. doi: 10.1542/peds.2007-1914. Pediatrics. 2008. PMID: 18381529 Review.
Cited by
-
Quality-of-life measures in asthma--do they matter to the GP?Br J Gen Pract. 1997 Jun;47(419):392-4. Br J Gen Pract. 1997. PMID: 9231478 Free PMC article.
-
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia.Pharmacoeconomics. 2000 Jun;17(6):611-20. doi: 10.2165/00019053-200017060-00007. Pharmacoeconomics. 2000. PMID: 10977398 Clinical Trial.
-
Economic and outcomes assessment of magnetic resonance imaging in the evaluation of headache.J Natl Med Assoc. 2000 Dec;92(12):573-8. J Natl Med Assoc. 2000. PMID: 11202760 Free PMC article.
-
The economic costs of asthma: a review and conceptual model.Pharmacoeconomics. 1993 Jul;4(1):14-30. doi: 10.2165/00019053-199304010-00004. Pharmacoeconomics. 1993. PMID: 10146965 Review.
-
NSAIDs and the elderly. Toxicity and economic implications.Drugs Aging. 1997 Feb;10(2):119-30. doi: 10.2165/00002512-199710020-00005. Drugs Aging. 1997. PMID: 9061269 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
